*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| C865 - Angioimmunoblastic T-cell lymphoma - as a primary diagnosis code | C865 - Angioimmunoblastic T-cell lymphoma - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 8.8 | |
| Readmission Rate (%) | 43.19 | |
| Unplanned Readmission Rate (%) | 24.7 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 823: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 016: AUTOLOGOUS BONE MARROW TRANSPLANT WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 841: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH COMPLICATION OR COMORBIDITY (CC) | DRG 824: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 29,081 | ||||
| Total Hospitalizations with ICD C865 - Angioimmunoblastic T-cell lymphoma | 125 | ||||
| DRG Share of Total Hospitalizations | 0.09 | ||||
| % of Total ICD C865 - Angioimmunoblastic T-cell lymphoma in DRG | 26.15 | ||||
| Avg LOS at DRG | 9.8 | ||||
| Avg LOS with ICD C865 - Angioimmunoblastic T-cell lymphoma | 12.34 | ||||
| Readmission Rate at DRG | 37.3 | ||||
| Readmission Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | 47.57 | ||||
| Unplanned Readmission Rate at DRG | 22.57 | ||||
| Unplanned Readmission Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | 31.07 | ||||
| Total Medicare payments at DRG | $683,745,757 | ||||
| Total Medicare payments with ICD C865 - Angioimmunoblastic T-cell lymphoma | $3,756,270 | ||||
| Total Medicare payment per Day at DRG | $2,399 | ||||
| Total Medicare payment per Day with ICD C865 - Angioimmunoblastic T-cell lymphoma | $2,434 | ||||
| Total Medicare payment per Hospitalization at DRG | $23,512 | ||||
| Total Medicare payment per Hospitalization with ICD C865 - Angioimmunoblastic T-cell lymphoma | $30,050 | ||||
| Total Medicare Charges at DRG | $3,049,100,784 | ||||
| Total Medicare Charges with ICD C865 - Angioimmunoblastic T-cell lymphoma | $16,443,071 | ||||
| Avg Charges at DRG | $104,849 | ||||
| Avg Charges with ICD C865 - Angioimmunoblastic T-cell lymphoma | $131,545 | ||||
| Mortality Rate at DRG | 13.07 | ||||
| Mortality Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | 11.2 | ||||
| SNF Discharge Rate at DRG | 16.93 | ||||
| SNF Discharge Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | 12.8 | ||||
| Home Discharge Rate at DRG | 29.4 | ||||
| Home Discharge Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | 35.2 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 842: LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|
| Total Hospitalizations at DRG | 6,280 |
| Total Hospitalizations with ICD C865 - Angioimmunoblastic T-cell lymphoma | 22 |
| DRG Share of Total Hospitalizations | 0.02 |
| % of Total ICD C865 - Angioimmunoblastic T-cell lymphoma in DRG | 4.6 |
| Avg LOS at DRG | 3.66 |
| Avg LOS with ICD C865 - Angioimmunoblastic T-cell lymphoma | 5.09 |
| Readmission Rate at DRG | 36.18 |
| Readmission Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | NA |
| Unplanned Readmission Rate at DRG | 17.17 |
| Unplanned Readmission Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | NA |
| Total Medicare payments at DRG | $48,340,480 |
| Total Medicare payments with ICD C865 - Angioimmunoblastic T-cell lymphoma | $226,994 |
| Total Medicare payment per Day at DRG | $2,103 |
| Total Medicare payment per Day with ICD C865 - Angioimmunoblastic T-cell lymphoma | $2,027 |
| Total Medicare payment per Hospitalization at DRG | $7,698 |
| Total Medicare payment per Hospitalization with ICD C865 - Angioimmunoblastic T-cell lymphoma | $10,318 |
| Total Medicare Charges at DRG | $249,811,104 |
| Total Medicare Charges with ICD C865 - Angioimmunoblastic T-cell lymphoma | $1,180,622 |
| Avg Charges at DRG | $39,779 |
| Avg Charges with ICD C865 - Angioimmunoblastic T-cell lymphoma | $53,665 |
| Mortality Rate at DRG | 1.59 |
| Mortality Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | NA |
| SNF Discharge Rate at DRG | 7.25 |
| SNF Discharge Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | NA |
| Home Discharge Rate at DRG | 68.04 |
| Home Discharge Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | 81.82 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 19 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 16 |
| BRIGHAM AND WOMEN'S HOSPITAL | 75 FRANCIS ST | BOSTON | MA | 02115 | 12 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 823: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 016: AUTOLOGOUS BONE MARROW TRANSPLANT WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 45,065 | ||||
| Total Hospitalizations with ICD C865 - Angioimmunoblastic T-cell lymphoma | 197 | ||||
| DRG Share of Total Hospitalizations | 0.14 | ||||
| % of Total ICD C865 - Angioimmunoblastic T-cell lymphoma in DRG | 10.71 | ||||
| Avg LOS at DRG | 4.03 | ||||
| Avg LOS with ICD C865 - Angioimmunoblastic T-cell lymphoma | 4.13 | ||||
| Readmission Rate at DRG | 66.75 | ||||
| Readmission Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | 73.54 | ||||
| Unplanned Readmission Rate at DRG | 10.94 | ||||
| Unplanned Readmission Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | 11.64 | ||||
| Total Medicare payments at DRG | $438,494,977 | ||||
| Total Medicare payments with ICD C865 - Angioimmunoblastic T-cell lymphoma | $2,024,034 | ||||
| Total Medicare payment per Day at DRG | $2,416 | ||||
| Total Medicare payment per Day with ICD C865 - Angioimmunoblastic T-cell lymphoma | $2,487 | ||||
| Total Medicare payment per Hospitalization at DRG | $9,730 | ||||
| Total Medicare payment per Hospitalization with ICD C865 - Angioimmunoblastic T-cell lymphoma | $10,274 | ||||
| Total Medicare Charges at DRG | $2,145,591,374 | ||||
| Total Medicare Charges with ICD C865 - Angioimmunoblastic T-cell lymphoma | $6,880,784 | ||||
| Avg Charges at DRG | $47,611 | ||||
| Avg Charges with ICD C865 - Angioimmunoblastic T-cell lymphoma | $34,928 | ||||
| Mortality Rate at DRG | 0.08 | ||||
| Mortality Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | NA | ||||
| SNF Discharge Rate at DRG | 4.35 | ||||
| SNF Discharge Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | NA | ||||
| Home Discharge Rate at DRG | 81.76 | ||||
| Home Discharge Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | 89.34 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 841: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH COMPLICATION OR COMORBIDITY (CC) | DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 824: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 25,646 | ||||
| Total Hospitalizations with ICD C865 - Angioimmunoblastic T-cell lymphoma | 80 | ||||
| DRG Share of Total Hospitalizations | 0.08 | ||||
| % of Total ICD C865 - Angioimmunoblastic T-cell lymphoma in DRG | 4.35 | ||||
| Avg LOS at DRG | 5.67 | ||||
| Avg LOS with ICD C865 - Angioimmunoblastic T-cell lymphoma | 6.29 | ||||
| Readmission Rate at DRG | 36.28 | ||||
| Readmission Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | 48.05 | ||||
| Unplanned Readmission Rate at DRG | 22.95 | ||||
| Unplanned Readmission Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | 27.27 | ||||
| Total Medicare payments at DRG | $299,718,477 | ||||
| Total Medicare payments with ICD C865 - Angioimmunoblastic T-cell lymphoma | $1,043,655 | ||||
| Total Medicare payment per Day at DRG | $2,062 | ||||
| Total Medicare payment per Day with ICD C865 - Angioimmunoblastic T-cell lymphoma | $2,075 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,687 | ||||
| Total Medicare payment per Hospitalization with ICD C865 - Angioimmunoblastic T-cell lymphoma | $13,046 | ||||
| Total Medicare Charges at DRG | $1,432,739,779 | ||||
| Total Medicare Charges with ICD C865 - Angioimmunoblastic T-cell lymphoma | $4,822,976 | ||||
| Avg Charges at DRG | $55,866 | ||||
| Avg Charges with ICD C865 - Angioimmunoblastic T-cell lymphoma | $60,287 | ||||
| Mortality Rate at DRG | 2.6 | ||||
| Mortality Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | NA | ||||
| SNF Discharge Rate at DRG | 13.23 | ||||
| SNF Discharge Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | NA | ||||
| Home Discharge Rate at DRG | 49.84 | ||||
| Home Discharge Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | 50.0 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 808: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 842: LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 23,754 | ||||
| Total Hospitalizations with ICD C865 - Angioimmunoblastic T-cell lymphoma | 42 | ||||
| DRG Share of Total Hospitalizations | 0.07 | ||||
| % of Total ICD C865 - Angioimmunoblastic T-cell lymphoma in DRG | 2.28 | ||||
| Avg LOS at DRG | 7.23 | ||||
| Avg LOS with ICD C865 - Angioimmunoblastic T-cell lymphoma | 10.9 | ||||
| Readmission Rate at DRG | 32.29 | ||||
| Readmission Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | 47.22 | ||||
| Unplanned Readmission Rate at DRG | 21.76 | ||||
| Unplanned Readmission Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | NA | ||||
| Total Medicare payments at DRG | $372,381,670 | ||||
| Total Medicare payments with ICD C865 - Angioimmunoblastic T-cell lymphoma | $1,017,662 | ||||
| Total Medicare payment per Day at DRG | $2,167 | ||||
| Total Medicare payment per Day with ICD C865 - Angioimmunoblastic T-cell lymphoma | $2,222 | ||||
| Total Medicare payment per Hospitalization at DRG | $15,677 | ||||
| Total Medicare payment per Hospitalization with ICD C865 - Angioimmunoblastic T-cell lymphoma | $24,230 | ||||
| Total Medicare Charges at DRG | $1,638,402,442 | ||||
| Total Medicare Charges with ICD C865 - Angioimmunoblastic T-cell lymphoma | $5,316,158 | ||||
| Avg Charges at DRG | $68,974 | ||||
| Avg Charges with ICD C865 - Angioimmunoblastic T-cell lymphoma | $126,575 | ||||
| Mortality Rate at DRG | 7.14 | ||||
| Mortality Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | NA | ||||
| SNF Discharge Rate at DRG | 14.42 | ||||
| SNF Discharge Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | NA | ||||
| Home Discharge Rate at DRG | 43.4 | ||||
| Home Discharge Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | 45.24 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 864: FEVER | DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 35,455 | ||||
| Total Hospitalizations with ICD C865 - Angioimmunoblastic T-cell lymphoma | 21 | ||||
| DRG Share of Total Hospitalizations | 0.11 | ||||
| % of Total ICD C865 - Angioimmunoblastic T-cell lymphoma in DRG | 1.14 | ||||
| Avg LOS at DRG | 3.24 | ||||
| Avg LOS with ICD C865 - Angioimmunoblastic T-cell lymphoma | 3.67 | ||||
| Readmission Rate at DRG | 20.75 | ||||
| Readmission Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | 60.0 | ||||
| Unplanned Readmission Rate at DRG | 14.51 | ||||
| Unplanned Readmission Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | NA | ||||
| Total Medicare payments at DRG | $191,023,146 | ||||
| Total Medicare payments with ICD C865 - Angioimmunoblastic T-cell lymphoma | $172,324 | ||||
| Total Medicare payment per Day at DRG | $1,661 | ||||
| Total Medicare payment per Day with ICD C865 - Angioimmunoblastic T-cell lymphoma | $2,238 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,388 | ||||
| Total Medicare payment per Hospitalization with ICD C865 - Angioimmunoblastic T-cell lymphoma | $8,206 | ||||
| Total Medicare Charges at DRG | $1,016,968,143 | ||||
| Total Medicare Charges with ICD C865 - Angioimmunoblastic T-cell lymphoma | $1,035,741 | ||||
| Avg Charges at DRG | $28,683 | ||||
| Avg Charges with ICD C865 - Angioimmunoblastic T-cell lymphoma | $49,321 | ||||
| Mortality Rate at DRG | 0.29 | ||||
| Mortality Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | NA | ||||
| SNF Discharge Rate at DRG | 12.41 | ||||
| SNF Discharge Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | NA | ||||
| Home Discharge Rate at DRG | 62.61 | ||||
| Home Discharge Rate with ICD C865 - Angioimmunoblastic T-cell lymphoma | 66.67 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 59 |
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 55 |
| STANFORD HEALTHCARE | 300 PASTEUR DR | STANFORD | CA | 94305 | 38 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. ELINA TSYVKIN | 281 LINCOLN ST | WORCESTER | MA | 01605 | 15 |